Maharashtra, India

Dinesh Rämesh Garud

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dinesh Rämesh Garud. Retrieved from https://idiyas.com/inventor/dinesh-rämesh-garud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dinesh Rämesh Garud: Innovator in Pharmaceutical Chemistry

Introduction

Dinesh Rämesh Garud is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.

Latest Patents

Dinesh holds a patent for a compound titled S-(−)-1-{4-[2-(allyloxy)-ethyl]phenoxy}-3-isopropylamino propan-2-ol. This invention relates to a novel compound and a process for its preparation. More specifically, it involves the selective allylation of p-hydroxy phenyl ethanol to create the compound, which is also convertible to S-(−)-betaxolol.

Career Highlights

Dinesh is associated with the Council of Scientific and Industrial Research, where he has been involved in various research projects aimed at advancing pharmaceutical sciences. His work has led to the development of innovative solutions that address critical health issues.

Collaborations

Dinesh has collaborated with esteemed colleagues such as Ramesh Anna Joshi and Muthukrishnan Murugan. These collaborations have fostered a productive research environment, enhancing the impact of their collective work.

Conclusion

Dinesh Rämesh Garud's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his role as a significant inventor in the field. His work continues to influence advancements in drug development and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…